BSE filing, NSE: CONCORDBIO. Summary written from the filing by ALFA Finder's alert engine.
Concord Biotech Ltd: key numbers
- Share price
- ₹632.60
- Market cap
- ₹13,236 Cr
- Revenue (annual)
- ₹1,055 Cr
- Net profit (annual)
- ₹260.9 Cr
- P/E (TTM)
- 46.9×Sector 43.0×
- Promoter holding
- 44.09%+0.01% QoQ
- FII holding
- 7.28%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Concord Biotech Ltd
All →Concord Biotech Earnings Call Transcript: Key Takeaways
Revenue grew 25% YoY driven by API demand, but gross margins contracted 400bps due to rising solvent costs and geopolitical disruptions.
- Call
- Guides 18% growth
Concord Biotech Investor Presentation: Key Takeaways
Q2FY27 consolidated revenue ₹309.1 Cr (+25%) and PAT ₹69.6 Cr (+10%); H1 revenue ₹566.6 Cr (+26%). Margins compressed; Inspira dermatology division launched.
Concord Biotech Bonus Issue
Concord Biotech fixed 4 November 2026 as the record date for a 1:1 bonus issue, with deemed allotment on 5 November 2026. The bonus is subject to statutory and regulatory approvals.
Concord Biotech Q2 FY27 Results: Net Profit ₹69.6 Cr, Up 10.3% YoY
Concord Biotech Ltd reported revenue from operations of ₹309.1 Cr (+25.1% YoY) and net profit of ₹69.6 Cr (+10.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹69.6 Cr · +10.3% YoY
Concord Biotech Bonus Issue
Concord Biotech's postal ballot approved a bonus issue and an authorised capital increase. No cash is paid and no ratio is stated.
Concord Biotech Board Meeting Date
Concord Biotech has scheduled its Q2 FY27 board meeting for 27 Oct 2026 to approve standalone and consolidated results. Trading window remains closed until 48 hours post result declaration.
Other bonus issue announcements
All →Pashupati Cotspin Bonus Issue
Pashupati Cotspin fixed 13 November 2026 as the record date for its 3:2 bonus issue. Shareholders on record will receive three bonus shares for every two held.
Sheetal Cool Products Bonus Issue
Sheetal Cool Products will hold a board meeting on November 12, 2026 to consider a bonus issue and stock split. Agenda also covers an authorised capital increase.
Bosch Bonus Issue
Bosch Limited's board recommended a 3:1 bonus issue on 6 November 2026, funded from free reserves. Shares are expected to be credited by 6 January 2027, subject to approvals.
- Execution
- Within 2 months from 06-11-2026 (credit by 06-01-2027)
Dharti Proteins Bonus Issue
Dharti Proteins shareholders approved a bonus share issue to public holders for minimum public shareholding compliance. All votes polled were in favour, 100% of votes cast.
AVENIQUE Bonus Issue
AVENIQUE LIMITED has issued notice for an extra-ordinary general meeting on 7 December 2026 via video conference. The single resolution seeks approval of a bonus share issue to public shareholders for minimum public shareholding compliance.
AVENIQUE Bonus Issue
Avenique's EGM on 7 December 2026 seeks approval for a 6-for-1 bonus issue to public shareholders. Record date is 11 December 2026; no cash is paid.